Ketamine's secret: family history of alcoholism may boost antidepressant effects

NCT ID NCT02122562

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study explores why ketamine, a fast-acting antidepressant, works better in people with a family history of alcohol use disorder. Researchers will give a single low-dose ketamine infusion to 60 adults with treatment-resistant depression while scanning their brains with powerful 7T MRI. They aim to measure changes in brain chemistry and connectivity to understand the biological reasons behind the enhanced response.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Ketamine
What this could lead to
If successful, this could help doctors personalize depression treatment by identifying who will benefit most from ketamine.
What could go wrong
This is a small, early-phase study (60 people) focused on understanding mechanisms, not proving effectiveness. Results may not apply to all depression patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOLISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Iowa Health Care

    RECRUITING

    Iowa City, Iowa, 52242, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.